MedPath

Comparative research on the effectiveness of dexmedetomidine and local anesthesia for surgically extracting mandibular third molars

Phase 2/3
Not yet recruiting
Conditions
Bilateral impacted tooth
Registration Number
CTRI/2023/06/054370
Lead Sponsor
Dr Heena Khan
Brief Summary

Pain is one of the most importantcomplications in the extraction of teeth which can even     cause the patients not willing to seekfurther dental treatment. Becoming aware of the need for a surgery evokesfeelings of fear and anxiety in many patients. Dexmedetomidineis a selective alpha‑2 adrenoceptor agonist. It is conventionally used as asedative in the intensive care unit.

However, recently, the application of dexmedetomidine as an adjuvantto a local anesthetic agent has been studied. The present study intends toevaluate the effectiveness of dexmedetomidine as an adjuvant to 2% lignocainewith adrenaline for surgical removal of impacted mandibular third molar.

A total of 15 patients who require surgical removal of impactedmandibular third molar extraction will be included in the study. Patients inthe study group will receive 2%

lignocaine and adrenaline with 1 mcg/ml dexmedetomidine. Patients inthe control group will receive 2% lignocaine with 1:200000 adrenaline. Theparameters for evaluation will be onset and duration of action, pulse rate,blood pressure, oxygen saturation, and blood loss along with patientsatisfaction score.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

1.ASA class I patient 2.Age group18-40 years 3.Bilateral similar impaction (with same classification and difficulty index).

Exclusion Criteria

1.Patients with a known history of an allergy or hypersensitivity to lignocaine or dexmedetomidine, 2.Pregnant or lactating mothers 3.Patients with acute pericoronitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Faster onset of local anaesthesia, prolonged duration of local anaesthesia, decrease in bleeding intraoperativelyOne and half year
Secondary Outcome Measures
NameTimeMethod
Better hemodynamic stabilityTwo weeks
Faster action of onsetOnce LA is injected (2-3 minutes)
Prolong duration of anaesthesiaAssessed from injecting LA to when the effect is weaned of (usually 2-3 hours)
Patient experiencePost operatively 1 - 2 hours
Decrease in bleedingAssessed after surgical extraction immediately

Trial Locations

Locations (1)

Yenepoya Dental College

🇮🇳

Kannada, KARNATAKA, India

Yenepoya Dental College
🇮🇳Kannada, KARNATAKA, India
Dr Heena Khan
Principal investigator
7303715994
drheenakhanx@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.